|
1. Tripoli E, La Guardia M, Giammanco S, Di Majo D. Giammanco M. Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review. Food Chem 2007;104(2): 466-79. 2. Suryawanshi JAS. An overview of Citrus aurantium used in treatment of various diseases. Afr J Plant Sci 2011; 5(7): 390-5. 3. Khorasani MA. Makhzan al Advieh. Tehran, Iran: Bavardaran Press Research institute for Islamic and Complementary Medicine, Iran University of Medical Sciences. 2001 .p. 4. Aghili Shirazi S. Qarabadin-e-Kabir. Tehran, Iran: Ostad Allah Qoli Khan Qajar. 1855. p.134. 5. Lopes CL, Gonçalves C, Almeida A, Pereira CJ, Costa MT, Mendes FC, et al. Sedative, anxiolytic and antidepressant activities of Citrus limon (Burn) essential oil in mice. Die Pharmazie- Int J Pharm Sci 2011; 66(8): 623-7. 6. Mosaddegh M, Kamalinejad M, Dehmaoobad Sharifabadi A, Esfahani, B. Composition of the volatile oils of the Citrus bigaradia, Citrus limon and Citrus deliciosa. J Med Plant 2004: 11(3): 25-30. 7. Jiang MH, Yang L, ZhuL, Piao JH, Jiang JG. Comparative GC/MS analysis of essential oils extracted by 3 methods from the bud of Citrus aurantium L. var. amara. Engl J Food Sci 2011; 76(9): 1219-25. 8. Moulehi I, Bourgou S, Ourghemmi I, Tounsi MS. Variety and ripening impact on phenolic composition and antioxidant activity of mandarin (Citrus reticulate Blanco) and bitter orange (Citrus aurantium L.) seeds extracts. Ind Crop Prod 2012; 1(39): 74-80. 9. Hansen, DK, George NI, White GE, Abdel-Rahman A, Pellicore L, Fabricant D. Cardiovascular toxicity of Citrus aurantium in exercised rats. Cardiovasc Toxicol 2013; 13(3): 208-19. 10. Liu L, Shan S, Zhang K, Ning ZQ, Lu XP, Cheng YY. Naringenin and hesperetin, two flavonoids derived from Citrus aurantium upregulate transcription of adiponectin. Phytother Res 2008; 22(10): 1400-3. 11. Kim GS, Park HJ, Woo JH, Kim MK, Koh PO, Min W, et al. Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells. BMC Complement Altern Med 2012; 12(31): 1-10. 12. Lee DH, Park KI, Park HS, Kang SR, Nagappan A, Kim JA, et al. Flavonoids isolated from Korea Citrus aurantium L. induce G2/M phase arrest and apoptosis in human gastric cancer AGS cells. Evid Based Complement Alternat Med 2012; 2012(1): 1-11. 13. Kang SR, Park KI, Park HS, Lee DH, Kim JA, Nagappan A, et al. Anti-inflammatory effect of flavonoids isolated from Korea Citrus aurantium L. on lipopolysaccharide-induced mouse macrophage RAW 264.7 cells by blocking of nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signalling pathways. Food Chem 2011; 129(4): 1721-8. 14. Karimi E, Oskoueian E, Hendra R, Oskoueian A, Jaafar HZ. Phenolic compounds characterization and biological activities of Citrus aurantium bloom. Molecules 2012; 17(2): 1203-18. 15. Fukumoto S, Morishita A, Furutachi K, Terashima T, Nakayama T, Yokogoshi H. Effect of flavour components in lemon essential oil on physical or psychological stress. Stress Health 2008; 24(1): 3-12. 16. Carvalho-Freitas MIR, Costa M. Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. Biol Pharm Bull 2002; 25(12): 1629-33. 17. Costa CA, Cury TC, Cassettari BO, Takahira RK, Flório JC, Costa M. Citrus aurantium L. essential oil exhibits anxiolytic-like activity mediated by 5-HT 1A-receptors and reduces cholesterol after repeated oral treatment. BMC Complement Altern Med 2013; 13(42): 1-10. 18. Calapai G, Firenzuoli F, Saitta A, Squadrito F, Arlotta MR, Costantino G, et al. Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report. Fitoterapia 1999; 70(6): 586-92. 19. Stohs SJ. Assessment of the adverse event reports associated with Citrus aurantium (bitter orange) from April 2004 to October 2009. J Funct Food 2010; 2(4): 235-8. 20. Louw VJ, Louw H. Citrus aurantium-beware of the bitter orange. SAMJ S Afr Med J 2008; 98(7): 496-6. 21. Chien K, Peau R, Farber J. Ischemic myocardial cell injury. Prevention by chlorpromazine of an accelerated phospholipid degradation and associated membrane dysfunction. Am J Pathol 1979; 97(3): 505-25. 22. Arteel GE, Sies H. The biochemistry of selenium and the glutathione system. Environ Toxicol Pharmacol 2001; 10(4): 153-8. 23. Alfa HH, Arroo RR. Over 3 decades of research on dietary flavonoid antioxidants and cancer prevention: What have we achieved?. Phytochem Rev 2019: 19(1):1-6. 24. Mojab F, Hamedi A, Nickavar B, Javidnia K. Hydrodistilled volatile constituents of the leaves of Daucus carota L. subsp. sativus (Hoffman.) Arcang.(Apiaceae) from Iran. J Essent Oil Bearing Pl. 2008; 11(3): 271-7. 25. Heidari R, Ghanbarinejad V, Mohammadi H, Ahmadi A, Esfandiari A, Azarpira N, et al. Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications. Biomed Pharmacother 2018; 99(1): 1022-32. 26. Heidari R, Taheri V, Rahimi HR, Yeganeh BS, Niknahad H, Najibi A. Sulfasalazine-induced renal injury in rats and the protective role of thiol-reductants. Renal Failure 2016; 38(1): 137-41. 27. Heidari R, Moezi L, Asadi B, Ommati MM, Azarpira N. Hepatoprotective effect of boldine in a bile duct ligated rat model of cholestasis/cirrhosis. Pharma Nutr 2017; 5(3): 109-17. 28. Khodabakhsh P, Shafaroodi H, Asgarpanah J. Analgesic and anti-inflammatory activities of Citrus aurantium L. blossoms essential oil (neroli): involvement of the nitric oxide/cyclic-guanosine monophosphate pathway. J Nat Med 2015; 69(3): 324-31. 29. Najafian S, Rowshan V. Comparative of HS SPME and HD techniques in Citrus aurantium L. Int J Med Arom Plants 2012; 2(1): 488-94. 30. Letizia C, Cocchiara J, Lalko J, Api A. Fragrance material review on linalyl acetate. Food Chem Toxicol 2003; 41(7): 965-76. 31. Ramos CA, Sá RD, Alves MF, Benedito RB, Sousa DP, Margareth de Fátima FM, et al. Histopathological and biochemical assessment of d-limonene-induced liver injury in rats. Toxicol Rep 2015; 1(2): 482-8. 32. Li J, Zhang X, Huang H. Protective effect of linalool against lipopolysaccharide/D- galactosamine-induced liver injury in mice. Int Immunopharmacol 2014; 23(2): 523-9. 33. Roffey SJ, Walker R, and Gibson G. Hepatic peroxisomal and microsomal enzyme induction by citral and linalool in rats. Food Chem Toxicol 1990; 28(6): 403-8. 34. Miyazawa M, Haigou R. Determination of cytochrome P450 enzymes involved in the metabolism of (−)-terpinen-4-ol by human liver microsomes. Xenobiotica 2011; 41(12): 1056-62. 35. Haigou R, Miyazawa M. Metabolism of (+)-Terpinen-4-ol by cytochrome P450 enzymes in human liver microsomes. J Oleo Sci 2012; 61(1): 35-43. 36. Nöldner M, Germer S, Koch E. Pharmacokinetics of linalool and linalyl acetate, the two main constituents of silexan, an essential oil from Lavandula angustifolia flowers, in rats. Planta Med 2011; 77(12): 1410-10.
|
.png){kind=logo}
